Cargando…
Resolution of Eosinophilic Pneumonia after Coronavirus Disease 2019 without Systemic Corticosteroids
Pulmonary and extrapulmonary complications after coronavirus disease 2019 (COVID-19) have been major public health concerns during the COVID-19 pandemic. Although post-COVID-19 pulmonary manifestations cover a wide spectrum, eosinophilic pneumonia (EP) has rarely been reported. To date, only four ca...
Autores principales: | Misaki, Yumiko, Hayashi, Yusuke, Shirata, Masahiro, Terada, Kazuhiro, Yoshizawa, Akihiko, Sakamoto, Ryo, Ikezoe, Kohei, Tanizawa, Kiminobu, Handa, Tomohiro, Hirai, Toyohiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society of Internal Medicine
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10686740/ https://www.ncbi.nlm.nih.gov/pubmed/37587039 http://dx.doi.org/10.2169/internalmedicine.1648-23 |
Ejemplares similares
-
Variation in information needs of patients with interstitial lung disease and their family caregivers according to long-term oxygen therapy: a descriptive study
por: Sato, Ryuhei, et al.
Publicado: (2023) -
Importance of serial changes in biomarkers in idiopathic pulmonary fibrosis
por: Sokai, Akihiko, et al.
Publicado: (2017) -
Matrix metalloproteinase-10: a novel biomarker for idiopathic pulmonary fibrosis
por: Sokai, Akihiko, et al.
Publicado: (2015) -
Comprehensive evaluation of airway involvement in pulmonary sarcoidosis
por: Tanizawa, Kiminobu, et al.
Publicado: (2017) -
Asymmetry in acute exacerbation of idiopathic pulmonary fibrosis
por: Sokai, Akihiko, et al.
Publicado: (2017)